Latest Cover
Prescriber is the leading UK journal for healthcare professionals focussing on prescribing and medicines management. The journal features articles on all areas of therapeutics and prescribing policy and is fully peer reviewed. The content is relevant and of interest to all prescribers and prescribing policy makers including GPs, pharmacists, nurses and hospital specialists. Access to all content is free to healthcare professionals following registration.Sign up for e-alerts and print copies

Latest News

New app assesses skin cancer risk

A new app that analyses moles and assesses the risk of skin cancer is now available. The SkinVision app offers a tool for analysing moles and other skin...Read more

Ibrutinib approved for Scottish patients with rare blood cancers

The Scottish Medicines Consortium (SMC) has recommended once daily ibrutinib (Imbruvica) for Scottish patients with specific types of rare and aggressive blood...Read more

Truvada granted authorisation for use as PrEP

The European Commission has granted marketing authorisation for the antiretroviral combination emtricitabine 200mg/tenofovir disoproxil 245mg (Truvada) to be...Read more

NICE recommends degarelix

Degarelix (Firmagon) is now recommended as a treatment for men with advanced hormone-dependent prostate cancer with spinal metastases. The drug is a selective...Read more

Genetic variant alters how well metformin works

New research by the Metformin Genetics Consortium has identified a genetic variant that alters how effective metformin is in people with type 2...Read more

Featured Articles

Assessment and management of viral croup in children
Croup is an acute respiratory illness that commonly affects preschool children. Although severe episodes requiring hospital admission occur in around 5 per cent of cases, the majority of children have a mild, self-limiting illness…
Click here to view

Ensuring NICE’s strategy is fit for the future
Professor David Haslam CBE has been chairman of NICE since 2013. A GP in Cambridgeshire for many years, Haslam’s gilded professional life has also included a stint as president of the BMA…
Click here to view

Use of direct oral anticoagulants in thromboembolic disease
Direct oral anticoagulants (DOACs) offer several advantages over warfarin in the management of thromboembolic disease. This article discusses their indications, mode of action, side-effects and interactions.
Click here to view

Web design and marketing agency Leamington Spa